Noradrenaline releasing effect of an ouabain-like compound on pulmonary artery

E. Vízi, F. Oberfrank, S. Bernath, D. Lichtstein

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The effect of ouabain and an endogenous ouabain-like compound (OLC) was studied on (3H)noradrenaline ((3H)NA) release from rabbit pulmonary artery. Similarly to ouabain, OLC enhanced the release of (3H)NA in response to electrical stimulation. These findings are the first evidence that OLC is able to act presynaptically and enhance the amount of (3H)NA release per impulse. It is suggested that this mechanism might be involved in the physiological regulation of blood pressure or in the genesis of hypertension.

Original languageEnglish
Pages (from-to)1541-1544
Number of pages4
JournalNeuropharmacology
Volume26
Issue number10
DOIs
Publication statusPublished - 1987

Fingerprint

Ouabain
Pulmonary Artery
Norepinephrine
Electric Stimulation
Rabbits
Blood Pressure
Hypertension

Keywords

  • hypertension
  • NaK-ATPase
  • noradrenaline release
  • ouabain-like compound
  • presynaptic modulation

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Noradrenaline releasing effect of an ouabain-like compound on pulmonary artery. / Vízi, E.; Oberfrank, F.; Bernath, S.; Lichtstein, D.

In: Neuropharmacology, Vol. 26, No. 10, 1987, p. 1541-1544.

Research output: Contribution to journalArticle

Vízi, E. ; Oberfrank, F. ; Bernath, S. ; Lichtstein, D. / Noradrenaline releasing effect of an ouabain-like compound on pulmonary artery. In: Neuropharmacology. 1987 ; Vol. 26, No. 10. pp. 1541-1544.
@article{2966bbd756ea4fc9ba9e661046d29eff,
title = "Noradrenaline releasing effect of an ouabain-like compound on pulmonary artery",
abstract = "The effect of ouabain and an endogenous ouabain-like compound (OLC) was studied on (3H)noradrenaline ((3H)NA) release from rabbit pulmonary artery. Similarly to ouabain, OLC enhanced the release of (3H)NA in response to electrical stimulation. These findings are the first evidence that OLC is able to act presynaptically and enhance the amount of (3H)NA release per impulse. It is suggested that this mechanism might be involved in the physiological regulation of blood pressure or in the genesis of hypertension.",
keywords = "hypertension, NaK-ATPase, noradrenaline release, ouabain-like compound, presynaptic modulation",
author = "E. V{\'i}zi and F. Oberfrank and S. Bernath and D. Lichtstein",
year = "1987",
doi = "10.1016/0028-3908(87)90177-8",
language = "English",
volume = "26",
pages = "1541--1544",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Noradrenaline releasing effect of an ouabain-like compound on pulmonary artery

AU - Vízi, E.

AU - Oberfrank, F.

AU - Bernath, S.

AU - Lichtstein, D.

PY - 1987

Y1 - 1987

N2 - The effect of ouabain and an endogenous ouabain-like compound (OLC) was studied on (3H)noradrenaline ((3H)NA) release from rabbit pulmonary artery. Similarly to ouabain, OLC enhanced the release of (3H)NA in response to electrical stimulation. These findings are the first evidence that OLC is able to act presynaptically and enhance the amount of (3H)NA release per impulse. It is suggested that this mechanism might be involved in the physiological regulation of blood pressure or in the genesis of hypertension.

AB - The effect of ouabain and an endogenous ouabain-like compound (OLC) was studied on (3H)noradrenaline ((3H)NA) release from rabbit pulmonary artery. Similarly to ouabain, OLC enhanced the release of (3H)NA in response to electrical stimulation. These findings are the first evidence that OLC is able to act presynaptically and enhance the amount of (3H)NA release per impulse. It is suggested that this mechanism might be involved in the physiological regulation of blood pressure or in the genesis of hypertension.

KW - hypertension

KW - NaK-ATPase

KW - noradrenaline release

KW - ouabain-like compound

KW - presynaptic modulation

UR - http://www.scopus.com/inward/record.url?scp=0023231041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023231041&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(87)90177-8

DO - 10.1016/0028-3908(87)90177-8

M3 - Article

VL - 26

SP - 1541

EP - 1544

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 10

ER -